Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA) Insider Trading
Directors, officers and holders of more than 10% of TNYA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 116 transactions on file: 0 with code P, 32 with code S and 18 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Ali Faraz | Chief Executive Officer | A Award | 732,500 | Not measured | Not measured |
| Sep 10, 2026 | Ali Faraz | Chief Executive Officer | A Award | 122,000 | Not measured | Not measured |
| Sep 10, 2026 | Tingley Whittemore | Chief Medical Officer | A Award | 293,000 | Not measured | Not measured |
| Sep 10, 2026 | Tingley Whittemore | Chief Medical Officer | A Award | 49,000 | Not measured | Not measured |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 1,637 | $0.7098 | $1,162 |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 2,279 | $0.7098 | $1,618 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 5,837 | $0.7097 | $4,143 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 3,969 | $0.7098 | $2,817 |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 1,871 | $0.7098 | $1,328 |
| Aug 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 1,637 | $0.7098 | $1,162 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 7,406 | $0.7097 | $5,256 |
| Aug 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 5,020 | $0.7097 | $3,563 |
| Jul 13, 2026 | Hyllengren Eric J | Chief Financial Officer | A Award | 1,650,000 | Not measured | Not measured |
| May 28, 2026 | Stehman-Breen Catherine | Director | A Award | 120,000 | Not measured | Not measured |
| May 28, 2026 | Lee June | Director | A Award | 120,000 | Not measured | Not measured |
| May 28, 2026 | Parschauer Karah Herdman | Director | A Award | 120,000 | Not measured | Not measured |
| May 28, 2026 | Burroughs Amy L. | Director | A Award | 120,000 | Not measured | Not measured |
| May 28, 2026 | Williams R Sanders | Director | A Award | 120,000 | Not measured | Not measured |
| May 28, 2026 | Walsh Jeffrey T. | Director | A Award | 120,000 | Not measured | Not measured |
| May 28, 2026 | Srivastava Deepak | Director | A Award | 120,000 | Not measured | Not measured |
| May 18, 2026 | Higa Tomohiro | SVP, Finance | S Sale | 1,485 | $0.7932 | $1,178 |
| May 18, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 3,121 | $0.7936 | $2,477 |
| May 18, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 3,390 | $0.7934 | $2,690 |
| Feb 25, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 1,862,545 | $0.5624 | $1,047,495 |
| Feb 25, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 1,649,281 | $0.5624 | $927,556 |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 349,212 | $0.6153 | $214,870 |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 309,228 | $0.6153 | $190,268 |
| Feb 23, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 143,709 | $0.5972 | $85,823 |
| Feb 23, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 162,291 | $0.5972 | $96,920 |
| Feb 20, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 277,769 | $0.6149 | $170,800 |
| Feb 20, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 245,965 | $0.6149 | $151,244 |
| Feb 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 1,642 | $0.6432 | $1,056 |
| Feb 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 3,979 | $0.6431 | $2,559 |
| Feb 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 1,642 | $0.6432 | $1,056 |
| Feb 17, 2026 | Tingley Whittemore | Chief Medical Officer | S Sale | 1,876 | $0.6431 | $1,206 |
| Feb 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 5,032 | $0.6430 | $3,236 |
| Feb 17, 2026 | Ali Faraz | Chief Executive Officer | S Sale | 5,851 | $0.6430 | $3,762 |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | S Sale | 611 | $0.6434 | $393 |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | S Sale | 836 | $0.6434 | $538 |
| Feb 17, 2026 | Higa Tomohiro | SVP, Finance | S Sale | 2,022 | $0.6431 | $1,300 |
| Feb 11, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 2,151,458 | $0.6808 | $1,464,713 |
| Feb 11, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 1,905,115 | $0.6808 | $1,297,002 |
| Feb 10, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 182,295 | $0.8161 | $148,771 |
| Feb 10, 2026 | COLUMN GROUP III GP, LP | 10% Owner | S Sale | 161,422 | $0.8161 | $131,736 |
| Feb 3, 2026 | Tingley Whittemore | Chief Medical Officer | A Award | 48,750 | Not measured | Not measured |
| Feb 3, 2026 | Higa Tomohiro | SVP, Finance | A Award | 175,500 | Not measured | Not measured |
| Feb 3, 2026 | Ali Faraz | Chief Executive Officer | A Award | 158,600 | Not measured | Not measured |
| Feb 3, 2026 | Higa Tomohiro | SVP, Finance | A Award | 29,250 | Not measured | Not measured |
| Feb 3, 2026 | Ali Faraz | Chief Executive Officer | A Award | 952,250 | Not measured | Not measured |
| Feb 3, 2026 | Tingley Whittemore | Chief Medical Officer | A Award | 318,500 | Not measured | Not measured |
The full Form 4 history is on the TNYA company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.